ROCKWELL MEDICAL, INC.

RMTI · Nasdaq · SIC 2834: Pharmaceutical Preparations
355
SEC Filings

Business Summary

Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. The company supplies liquid and dry acid and bicarbonate concentrates for dialysis patients, primarily in the United States. Products are manufactured at facilities in Michigan and Texas under cGMP regulations and delivered to dialysis clinics via company trucks and third-party carriers. Rockwell serves 294 customers including all five leading U.S. dialysis providers.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRMTIdiscussed_in_filing Cybersecurity
topic_mentionRMTIdiscussed_in_filing Trusted Computing
topic_mentionRMTIdiscussed_in_filing Blockchain & Crypto
topic_mentionRMTIdiscussed_in_filing Capital Expenditure
topic_mentionRMTIdiscussed_in_filing Supply Chain
topic_mentionRMTIdiscussed_in_filing Regulation
topic_mentionRMTIdiscussed_in_filing Healthcare & Bio
topic_mentionRMTIdiscussed_in_filing Sovereign & Government
topic_mentionRMTIdiscussed_in_filing Cybersecurity
topic_mentionRMTIdiscussed_in_filing Trusted Computing
topic_mentionRMTIdiscussed_in_filing Blockchain & Crypto
topic_mentionRMTIdiscussed_in_filing Capital Expenditure
topic_mentionRMTIdiscussed_in_filing Supply Chain
topic_mentionRMTIdiscussed_in_filing Regulation
topic_mentionRMTIdiscussed_in_filing Healthcare & Bio
topic_mentionRMTIdiscussed_in_filing Sovereign & Government
topic_mentionRMTIdiscussed_in_filing Cybersecurity
topic_mentionRMTIdiscussed_in_filing Trusted Computing
topic_mentionRMTIdiscussed_in_filing Blockchain & Crypto
topic_mentionRMTIdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001628280-26-021186EDGAR45K words
2025-03-202024-12-310001628280-25-013983EDGAR—
2024-03-212023-12-310001628280-24-012572EDGAR—
2023-03-302022-12-310001628280-23-009774EDGAR—
2022-04-082021-12-310001628280-22-008830EDGAR—
2021-03-312020-12-310001628280-21-006280EDGAR—
2020-03-172019-12-310001628280-20-003683EDGAR—
2019-03-182018-12-310001558370-19-002200EDGAR—
2018-03-152017-12-310001558370-18-002142EDGAR—
2017-03-152016-12-310001558370-17-001846EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001628280-25-051290EDGAR19K words
2025-08-142025-06-300001041024-25-000011EDGAR—
2025-05-122025-03-310001628280-25-024434EDGAR—
2024-11-122024-09-300001628280-24-046839EDGAR—
2024-08-082024-06-300001628280-24-035859EDGAR—
2024-05-142024-03-310001628280-24-023056EDGAR—
2023-11-142023-09-300001628280-23-038781EDGAR—
2023-08-142023-06-300001628280-23-029168EDGAR—
2023-05-152023-03-310001628280-23-017994EDGAR—
2022-11-142022-09-300001628280-22-029627EDGAR—
2022-08-152022-06-300001628280-22-022899EDGAR—
2022-05-162022-03-310001628280-22-014502EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001628280-26-021195EDGAR1K words
2026-03-260001628280-26-021176EDGAR—
2026-01-200001628280-26-002478EDGAR—
2026-01-050001628280-26-000221EDGAR—
2025-11-180001104659-25-113452EDGAR—
2025-11-120001628280-25-051311EDGAR—
2025-11-120001628280-25-051267EDGAR—
2025-09-290001104659-25-094524EDGAR—
2025-08-140001041024-25-000009EDGAR—
2025-05-200001104659-25-050997EDGAR—

355 total filings indexed. 323 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

hemodialysis-concentrate-supply end-stage-kidney-disease-treatment freestanding-outpatient-dialysis-centers hospital-based-outpatient-dialysis-centers skilled-nursing-facilities home-dialysis international-dialysis-providers cgmp-(current-good-manufacturing-practices) aami-(association-for-the-advancement-of-medical-instrumentation)-guidelines fda-510(k)-approval

Company Identity

CIK0001041024
TickerRMTI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersWixom, Michigan

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b841e713c2a6b785a57936f38ebdf3befac9b62e44947644dfa97330aa04f666
parent: 575513bf0a67b0e3831207c34e8e56955e39e1a56a5c1b2137d97720aee0eb30
content hash: 769de0dc44987ca874b0ba1b45f56da46917075191e1460856a626a0dbec2d89
signed: 2026-04-13T04:47:13.720Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf